cagrisema vs semaglutide Cagrilintide–semaglutide (CagriSema) versus or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study Comparative Weight Loss With CagriSema,

By providing a concentrated, long-acting version of this hormone, the semaglutide allows patients to feel full on significantly smaller portions of food

I always wonder if a comparison to much smaller groups means that incidental side effects that arent related to the drug in the smaller group (in this case in both the placebo and 2.4mg group) might be making the side effects, especially things that are more common generally, from the drug seem more even than they are

With all the traditional tools of a dietitian, plus specialized insights into exercise therapy, they can develop strong plans to help patients feel better and stay stronger through their course of therapy

Acta Anaesthesiologica Scandinavica